TAHP for Patients With HER2-positive Early Breast Cancer and Subsequent AHP Adjuvant tHerapy After Surgery

Condition:   HER2-positive Breast Cancer Interventions:   Drug: TAHP and AHP;   Drug: TAHP plus AC and AHP Sponsor:   Samsung Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials